The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice

European Journal of Pharmacology

Volumn 524, Issue 1-3, 2005, Pages 149-154

  Tamura, Tadafumi ^a   Amano, Toru ^a   Ohmori, Kenji ^a   Manabe, Haruhiko ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Animal model; Atopic dermatitis; Histamine H1 receptor antagonist; Olopatadine hydrochloride; Scratching

Indexed keywords

BETOTASTINE; CHLORPHENIRAMINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 4; LORATADINE; NERVE GROWTH FACTOR; OLOPATADINE; OXAZOLONE; PREDNISOLONE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; EAR; EDEMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS INHIBITION; PRURITUS; RECEPTOR BLOCKING; SCRATCHING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIPRURITICS; CHLORPHENIRAMINE; CYTOKINES; DERMATITIS, CONTACT; DIBENZOXEPINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR; HISTAMINE H1 ANTAGONISTS; IMMUNOGLOBULIN E; MALE; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTOR; OXAZOLONE; PREDNISOLONE; PRURITUS; SEVERITY OF ILLNESS INDEX;

EID: 27744595347     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.09.004     Document Type: Article

References (32)

1. M.M. Abdelaziz, J.L. Devalia, O.A. Khair, H. Bayram, A.J. Prior, and R.J. Davies Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis J. Allergy Clin. Immunol. 101 1998 410 420
2. T. Andoh, H. Itoh, I. Watanabe, T. Sasaki, and T. Higashi Mechanisms of modulation of neuronal nicotinic receptors by substance P and OAG Am. J. Physiol. Cell Physiol. 281 2001 C1871 C1880
3. J.D. Bos, E.A. Wierenga, Sillevis, J.H. Smitt, F.L. van der Heijden, and M.L. Kapsenberg Immune dysregulation in atopic eczema Arch. Dermatol. 128 1992 1509 1512
4. H.A. Bull, T.A. Leslie, S. Chopra, and P.M. Dowd Expression of nerve growth factor receptors in cutaneous inflammation Br. J. Dermatol. 139 1998 776 783
5. G.J. Burbach, K.H. Kim, A.S. Zivony, A. Kim, J. Aranda, S. Wright, S.M. Naik, S.W. Caughman, J.C. Ansel, and C.A. Armstrong The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor J. Invest. Dermatol. 117 2001 1075 1082
6. E.B. Cook, J.L. Stahl, N.P. Barney, and F.M. Graziano Olopatadine inhibits TNFα release from human conjunctival mast cells Ann. Allergy Asthma Immunol. 84 2000 504 508
7. M.L. Giustizieri, C. Albanesi, J. Fluhr, P. Gisondi, J. Norgauer, and G. Girolomoni H1 histamine receptor mediates inflammatory responses in human keratinocytes J. Allergy Clin. Immunol. 114 2004 1176 1182
8. M. Grewe, K. Gyufko, E. Schopf, and J. Krutmann Lesional expression of interferon-gamma in atopic eczema Lancet 343 1994 25 26
9. M. Grewe, C.A. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A.G. Langeveld-Wildschut, T. Ruzicka, and J. Krutmann A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis Immunol. Today 19 1998 359 361
10. K. Hayashi, T. Kaise, K. Ohmori, A. Ishii, and A. Karasawa Effects of olopatadine hydrochloride on the cutaneous vascular hyperpermeability and the scratching behavior induced by poly-l-arginine in rats Jpn. J. Pharmacol. 87 2001 167 170
11. L. Horsmanheimo, I.T. Harvima, A. Jarvikallio, R.J. Harvima, A. Naukkarinen, and M. Horsmanheimo Mast cells are one major source of interleukin-4 in atopic dermatitis Br. J. Dermatol. 131 1994 348 353
12. H.R. Jin, Y. Okamoto, Z. Matsuzaki, S. Endo, and E. Ito Cetirizine decreases interleukin-4, interleukin-5, and interferon-γ gene expressions in nasal-associated lymphoid tissue of sensitized mice Am. J. Rhinol. 16 2002 43 48
13. A.B. Kay, S. Ying, V. Varney, M. Gaga, S.R. Durham, R. Moqbel, A.J. Wardlaw, and Q. Hamid Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects J. Exp. Med. 173 1991 775 778
14. I. Kinkelin, S. Motzing, M. Koltenzenburg, and E.B. Brocker Increase in NGF content and nerve fiber sprouting in human allergic contact eczema Cell Tissue Res. 302 2000 31 37
15. H. Kitagaki, N. Ono, K. Hayakawa, T. Kitazawa, K. Watanabe, and T. Shiohara Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile J. Immunol. 159 1997 2484 2491
16. C.S. Koblenzer Itching and the atopic skin J. Allergy Clin. Immunol. 104 1999 S109 S113
17. M. Kojima, M. Aihara, M. Yamada, S. Matsukura, T. Hirasawa, and Z. Ikezawa Effects of neuropeptides in the development of the atopic dermatitis of mouse models Allergol. Intern. 53 2004 169 178
18. U. Lippert, A. Moller, P. Welker, M. Artuc, and B.M. Henz Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists Exp. Dermatol. 9 2000 118 124
19. M. Matsubara, T. Tamura, K. Ohmori, and K. Hasegawa Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/IκB/NF-κB signal cascades Biochem. Pharmacol. 69 2005 433 449
20. K. Ohmori, K. Hayashi, T. Kaise, E. Ohshima, S. Kobayashi, T. Yamazaki, and A. Mukouyama Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug Jpn. J. Pharmacol. 88 2002 379 397
21. C. Pincelli Nerve growth factor and keratinocytes: a role in psoriasis Eur. J. Dermatol. 10 2000 85 90
22. R. Rossi, and O. Johansson Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview Eur. J. Dermatol. 8 1998 299 306
23. T. Scholzen, C.A. Armstrong, N.W. Bunnett, T.A. Luger, J.E. Olerud, and J.C. Ansel Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems Exp. Dermatol. 7 1998 81 96
24. S. Stander, M. Steinhoff, M. Schmelz, E. Weisshaar, D. Metze, and T. Luger Neurophysiology of pruritus: cutaneous elicitation of itch Arch. Dermatol. 139 2003 1463 1470
25. Y. Sugimoto, Y. Ishihara, R. Kayasuga, M.A. Hossen, C. Kamei, and T. Watanabe Evaluation of olopatadine using histamine H1 receptor-deficient mice Jpn. J. Allergol. 52 2003 477P (in Japanese)
26. T. Tamura, M. Matsubara, C. Takada, K. Hasegawa, K. Suzuki, K. Ohmori, and A. Karasawa Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice Br. J. Dermatol. 151 2004 1133 1142
27. M. Toyoda, M. Nakamura, T. Makino, T. Hino, M. Kagoura, and M. Morohashi Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis Br. J. Dermatol. 147 2002 71 79
28. M. Toyoda, M. Nakamura, T. Makino, and M. Morohashi Localization and content of nerve growth factor in peripheral blood eosinophils of atopic dermatitis patients Clin. Exp. Allergy 33 2003 950 955
29. H. Uchi, H. Terao, T. Koga, and M. Furue Cytokines and chemokines in the epidermis J. Dermatol. Sci. 24 2000 S29 S38
30. J.M. Yanni, L.K. Weimer, N.A. Sharif, S.X. Xu, D.A. Gamache, and J.M. Spellman Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs Arch. Ophthalmol. 117 1999 643 647
31. C.F. Wahlgren Itch and atopic dermatitis: an overview J. Dermatol. 26 1999 770 779
32. E.F. Webb, M.N. Tzimas, S.J. Newsholme, and D.E. Griswold Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor α and interleukin-4 J. Invest. Dermatol. 111 1998 86 92